- Sputnik International
Asia
Find top stories and features from Asia and the Pacific region. Keep updated on major political stories and analyses from Asia and the Pacific. All you want to know about China, Japan, North and South Korea, India and Pakistan, Southeast Asia and Oceania.

China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports

© REUTERS / TINGSHU WANGA signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020.
A signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. - Sputnik International
Subscribe
BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus, the China Central Television reported.

On Wednesday, Sinopharm’s subsidiary Beijing Institute of Biological Products said that the efficiency of its vaccine had exceeded 79 percent. The vaccine has already been approved by Bahrain and the United Arab Emirates.

The scientists will reportedly continue to study the efficiency of the vaccine.

© AP Photo / Zhang YuweiIn this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing.
China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports - Sputnik International
In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing.

According to earlier statements of Sinopharm, about 1 million people have already been vaccinated with its drug, including 60,000 people outside China.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала